DK41592A - Ravsyreforbindelser - Google Patents

Ravsyreforbindelser Download PDF

Info

Publication number
DK41592A
DK41592A DK041592A DK41592A DK41592A DK 41592 A DK41592 A DK 41592A DK 041592 A DK041592 A DK 041592A DK 41592 A DK41592 A DK 41592A DK 41592 A DK41592 A DK 41592A
Authority
DK
Denmark
Prior art keywords
group
isomers
carbon atoms
atom
lower alkyl
Prior art date
Application number
DK041592A
Other languages
English (en)
Other versions
DK170973B1 (da
DK41592D0 (da
Inventor
Fumiyasu Sato
Atsushi Tsubaki
Hiroshi Hokari
Nobuyuki Tanaka
Masaru Saito
Kenji Akahane
Michihiro Kobayashi
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3142275A external-priority patent/JP2686861B2/ja
Priority claimed from JP3188416A external-priority patent/JP2686863B2/ja
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of DK41592D0 publication Critical patent/DK41592D0/da
Publication of DK41592A publication Critical patent/DK41592A/da
Application granted granted Critical
Publication of DK170973B1 publication Critical patent/DK170973B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04Polysiloxanes
    • C08G77/06Preparatory processes
    • C08G77/08Preparatory processes characterised by the catalysts used
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Polymers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
DK041592A 1991-03-30 1992-03-27 Ravsyreforbindelser og farmaceutiske præparater indeholdende dem DK170973B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP3142275A JP2686861B2 (ja) 1991-03-30 1991-03-30 新規なベンジリデンコハク酸誘導体
JP14227591 1991-03-30
JP3188416A JP2686863B2 (ja) 1991-04-25 1991-04-25 新規なベンジルコハク酸誘導体
JP18841691 1991-04-25
JP36151991 1991-12-27
JP36151991 1991-12-27

Publications (3)

Publication Number Publication Date
DK41592D0 DK41592D0 (da) 1992-03-27
DK41592A true DK41592A (da) 1992-10-01
DK170973B1 DK170973B1 (da) 1996-04-09

Family

ID=27318415

Family Applications (1)

Application Number Title Priority Date Filing Date
DK041592A DK170973B1 (da) 1991-03-30 1992-03-27 Ravsyreforbindelser og farmaceutiske præparater indeholdende dem

Country Status (11)

Country Link
US (1) US5202335A (da)
EP (1) EP0507534B1 (da)
KR (1) KR100192530B1 (da)
AT (1) ATE134615T1 (da)
AU (1) AU654331B2 (da)
CA (1) CA2062877C (da)
DE (1) DE69208496T2 (da)
DK (1) DK170973B1 (da)
ES (1) ES2084275T3 (da)
FI (1) FI102172B1 (da)
NO (1) NO178371C (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0967204A4 (en) * 1997-01-29 2000-11-29 Kissei Pharmaceutical METHOD FOR THE PRODUCTION OF BENZYL succinic acid ester derivatives
FR2765578B1 (fr) * 1997-07-03 1999-09-10 Adir Procede de preparation d'un perhydroisoindole substitue
JP3277320B2 (ja) * 1997-08-28 2002-04-22 有機合成薬品工業株式会社 シス−ヘキサヒドロイソインドリン誘導体の製造方法
FR2777566B1 (fr) * 1998-04-15 2003-02-21 Synthelabo Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2779428B1 (fr) * 1998-06-03 2001-05-18 Synthelabo Derives d'oxo-azacycloalcanes, leurs preparations et leurs applications en therapeutique
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
FR2793411B1 (fr) * 1999-05-11 2001-06-29 Synthelabo Utilisation de derives de l'acide succinique pour obtenir un medicament destine au traitement de l'inflammation
WO2000071117A1 (en) 1999-05-21 2000-11-30 Kissei Pharmaceutical Co., Ltd. Immediate release medicinal compositions for oral use
PE20020617A1 (es) 2000-08-22 2002-08-05 Novartis Ag Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
KR20020092060A (ko) * 2001-06-01 2002-12-11 김정균 알콕시 작용성 그룹을 포함한 폴리실록산 화합물
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
EP1757287A4 (en) * 2004-05-11 2009-11-25 Kissei Pharmaceutical PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LIPID METABOLISM DISORDERS
US20070254938A1 (en) * 2004-07-01 2007-11-01 Kiyoshi Ichikawa Preventive or Therapeutic Agent for Vascular Intimal Proliferative Disease
EP1796687A2 (en) * 2004-09-14 2007-06-20 Elixir Pharmaceuticals, Inc. Combination therapy for controlled carbohydrate digestion
CN1634885B (zh) * 2004-11-09 2011-05-04 北京乐力健生物科技有限公司 米格列奈晶型及其制备方法
CN1324010C (zh) * 2005-01-12 2007-07-04 江苏省药物研究所 一种米格列奈的制备方法
WO2006080524A1 (ja) * 2005-01-31 2006-08-03 Ajinomoto Co., Inc. 血糖降下剤を含有する、耐糖能異常、境界型糖尿病、インスリン抵抗性及び高インスリン血症の改善ないし治療用医薬組成物
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
CA2628506A1 (en) * 2005-11-07 2007-05-18 Elixir Pharmaceuticals, Inc. Combinations of metformin and meglitinide
WO2009047797A2 (en) * 2007-10-08 2009-04-16 Ind-Swift Laboratories Limited Process for the preparation of perhydroisoindole derivative
KR20110074614A (ko) * 2009-03-19 2011-06-30 고쿠리츠 다이가쿠 호진 교토 다이가쿠 췌도 이미징용 분자 프로브 전구체 및 그 사용
NZ596302A (en) 2009-05-15 2014-01-31 Novartis Ag Aryl pyridine as aldosterone synthase inhibitors
US8455522B2 (en) 2009-05-15 2013-06-04 Novartis Ag Benzoxazolone derivatives as aldosterone synthase inhibitors
JP5466759B2 (ja) 2009-05-28 2014-04-09 ノバルティス アーゲー ネプリライシン阻害剤としての置換アミノ酪酸誘導体
SG176009A1 (en) 2009-05-28 2011-12-29 Novartis Ag Substituted aminopropionic derivatives as neprilysin inhibitors
US8519134B2 (en) 2009-11-17 2013-08-27 Novartis Ag Aryl-pyridine derivatives as aldosterone synthase inhibitors
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
ES2472446T3 (es) 2009-11-30 2014-07-01 Novartis Ag Derivados de imidazol como inhibidores de aldosterona sintasa
CN101973926B (zh) * 2010-11-05 2012-09-19 威海迪素制药有限公司 R-米格列奈钙的制备方法
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
WO2013189829A1 (en) 2012-06-22 2013-12-27 Laboratorios Lesvi, S. L. Process for obtaining (s)-2-benzyl-4-((3ar,7as)-hexahydro-1 h-isoindol- 2(3h)-yl)-4-oxobutanoic acid and salts thereof
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
TR201808541T4 (tr) 2013-02-14 2018-07-23 Novartis Ag Nep (nötr endopeptidaz) inhibitörleri olarak ikame edilmiş bisfenil butanoik fosfonik asit türevleri.
HK1218252A1 (zh) 2013-07-25 2017-02-10 Novartis Ag 合成apelin多肽之生物结合物
KR20160031551A (ko) 2013-07-25 2016-03-22 노파르티스 아게 심부전의 치료를 위한 시클릭 폴리펩티드
MA41580A (fr) 2015-01-23 2017-11-29 Novartis Ag Conjugués d'acides gras de l'apeline synthétique présentant une demi-vie améliorée
CN106631978B (zh) * 2016-12-29 2020-03-24 千辉药业(安徽)有限责任公司 一种米格列奈中间体的合成工艺
UY38072A (es) 2018-02-07 2019-10-01 Novartis Ag Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303662A (en) * 1980-11-24 1981-12-01 E. R. Squibb & Sons, Inc. Carboxyacyl, mercapto and acylmercapto derivatives of heterobicyclo compounds
US4479963A (en) * 1981-02-17 1984-10-30 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
ES2061432T3 (es) * 1985-10-09 1994-12-16 Shell Int Research Nuevas amidas de acido acrilico.
FR2672598A1 (fr) * 1991-02-11 1992-08-14 Adir Nouveaux inhibiteurs de n-myristoyltransferase, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
FI102172B (fi) 1998-10-30
CA2062877C (en) 2002-07-02
KR930019682A (ko) 1993-10-18
HK1005449A1 (en) 1999-01-08
AU1280992A (en) 1992-10-01
EP0507534A1 (en) 1992-10-07
NO921200L (no) 1992-10-01
ATE134615T1 (de) 1996-03-15
FI921392A0 (fi) 1992-03-30
CA2062877A1 (en) 1992-10-01
KR100192530B1 (ko) 1999-06-15
FI921392L (fi) 1992-10-01
NO178371C (no) 1996-03-13
DK170973B1 (da) 1996-04-09
DE69208496T2 (de) 1996-10-17
DK41592D0 (da) 1992-03-27
AU654331B2 (en) 1994-11-03
EP0507534B1 (en) 1996-02-28
NO921200D0 (no) 1992-03-27
FI102172B1 (fi) 1998-10-30
ES2084275T3 (es) 1996-05-01
DE69208496D1 (de) 1996-04-04
US5202335A (en) 1993-04-13
NO178371B (no) 1995-12-04

Similar Documents

Publication Publication Date Title
NO178371C (no) Ravsyreforbindelser
DE69331414D1 (de) Depsipeptide, herstellung und anwendung
EP1043317A4 (en) PYRIDAZINE DERIVATIVES AND MEDICINES CONTAINING THE SAME AS ACTIVE INGREDIENTS
AU636330B2 (en) N-phenyl-n-(4-piperidinyl)amides useful as analgesics
AU679761B2 (en) 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives as 5HT1A ligands
IE893246L (en) Biologically active compounds
ATE34981T1 (de) Phenoxyalkoxy-3,4-dihydro-2h-1benzopyranderivate.
ATE131478T1 (de) 4-((2-benzothiazolyl)methylamino>-alpha-(3,4- difluorphenoxy)methyl-1-piperidenethanol
EP0312269A3 (en) 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as h3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents ypocholesterolemic agents
MY101140A (en) Benzoylurea compounds, and pesticidal and pharmaceutical compositions comprising same
RU94037965A (ru) Производные бензоксазола в виде рацемата или отдельных энантиомеров и их фармацевтически приемлемые соли и фармацевтические композиции с ингибирующей биосинтез лейкотриенов активностью
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие
ATE151987T1 (de) Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl
KR970705540A (ko) 구아니디노메틸 사이클로헥산 카복실산 에스테르 유도체(Guanidinomethyl cyclohexane carboxylic ester derivative)
NO169837C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive forbindelser
DE69006607D1 (de) Verfahren zur Herstellung von Carbamaten und dabei auftretende Zwischenprodukte.
ATE223406T1 (de) 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression
AU4574900A (en) Use of succinic acid derivatives to obtain a medicine for treating inflammation
HUT49845A (en) Process for producing optically active n-substituted alanine derivatives with herbicidal effect

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK